Dominic Adair > Bristows LLP > London, England > Lawyer Profile

Bristows LLP
100 VICTORIA EMBANKMENT
LONDON
EC4Y 0DH
England

Living Wage

Work Department

Patent Litigation

Position

Dominic specialises in contentious intellectual property matters, with an emphasis on patent litigation.

Reflecting his technical background, Dominic focuses primarily in life sciences disputes, particularly in relation to pharmaceuticals and biotechnology. Dominic has handled cases across the range of tribunals in the UK and the EPO and has coordinated litigation across Europe and the world.

In the pharmaceutical and biotechnology sector, Dominic has worked on all aspects of the drug life cycle, from freedom to operate analyses and early-stage risk assessment of generic competition to complex end-stage litigation, SPCs and anti-trust issues. His extensive experience of cross-border litigation has involved acting for both rights holders and defendants, giving him the broadest possible outlook on strategy and a comprehensive tactical playbook.

Dominic has also handled patent litigation for several household names in the consumer products sector on cases ranging from beer containers to shaving products.

Dominic writes regularly on reported patent cases in the UK and at the EPO and is a regular conference speaker and presenter. He is a member of CIPA, EPLAW and AIPPI and holds office as the Honorary Secretary of AIPPI UK.

Career

Trained at Bristows
Qualified in 2004
Partner since 2014

Memberships

CIPA, EPLAW and AIPPI

Education

MA Natural Sciences, University of Cambridge
PhD Zoology, University of Cambridge
Diploma in Intellectual Property Law and Practice, University of Bristol

Leisure

Running, cycling and spending time with family.

Lawyer Rankings

London > TMT (technology, media and telecoms) > Intellectual property: patents (contentious and non-contentious)

Praised by clients as an ‘extremely experienced and very well-established’ team, Bristows LLP’s one-stop shop is notable for its capabilities in handling technology, life science and consumer products. The team is involved in cutting-edge work in SEP/FRAND cases, alongside pharmaceuticals, including important biologics and antibodies cases. On the transactional side, the team routinely handles IP deals including settlements, high value research collaboration and licensing deals, and IP aspects of corporate and JV transactions. Andrew Bowler and Myles Jelf jointly lead the patent litigation practice, the former is well-versed in coordinating global litigation and the latter is noted for his expertise in telecommunication and high tech matters. Matthew Warren leads the transactional side of the practice, his most notable work includes a landmark research collaboration and licence agreement between Oxford University Innovation and AstraZeneca. Claire Smith is another name to note on the transactional side. Liz Cohen’s strengths lie in the realm of life sciences, while James Boon is sought after by clients in the telecoms and high-tech sectors. Other patent litigation specialists include Gemma BarrettRichard Pinckney, Robert Burrows, Dominic Adair and Brian Cordery.